Portrait of the Global Health Group

Short portrait

The Global Health Group AG sees itself as a management holding company that supports other innovative companies with a ‘hands-on’ approach. The company’s CEO accompanies and supports all of the Global Health Group AG’s investments. He offers practical knowledge, branch expertise and his international and worldwide contacts to industry, research and development, as well as capital market experts.

The company focuses on identifying innovative business ideas, which primarily require being made market-ready and need to be introduced to the capital market at the perfect time, at an early stage. In the process, the operational business is conducted as much as possible within the investments. The Global Health Group AG focuses on the consumer and health sector.

At the moment, the Global Health Group AG is primarily invested with the Babys Life Deutschland GmbH and the Babys Life Brands Ltd. The company’s focus lies on the development of so-called “liquid functional food and beverages” in the segment of dietary supplements.

In cooperation with our partners, the Global Health Group focuses on the acquisition of, the investment in or the cooperation with external young companies with brilliant ideas and a high level of innovation. We focus on analyzing and evaluating their targeted markets and determining the best direct or indirect synergy effects. At the same time, we offer important resources, core competency and market access.

Company details

Founding year 1972
End of the financial year December 31
Accounting standards Swiss Code of Obligations
Shares by piece 6.700.000
Shares in CHF 670.000
Nominal value per share (in CHF) 0.10
Administrative board Marc Wallendorf

Share details

Number of shares 6.700.000
ISIN CH0121668229
Euronext Code MLIFE
Type of shares Bearer shares
Original Clearing SIX-SIS

Company details at stock market launch

Name IPO
Stock exchange Euronext
Transparency standard at initial listing Marché Libre
Type of transaction Listing
ICB Sector 3577 – Food Products
Country Switzerland
Trading symbol MLIFE
First day of trading July 15, 2015
Issuance process Direct Listing
First price 4.50 EUR
Listing sponsor Capital for Markets

Shareholder structure at initial listing

shareholder shares in %
SETEC Stiftung 66.21 %
MI Group Ltd. 12.50 %
ADAG LLC 6.10 %
Free float 15.19%
Important note: This website and the information contained therein do not represent an encouragement or invitation to buy, sell or conduct any other type of trade in securities of the Global Health Group AG in Switzerland or any other country. Shares of the Global Health Group AG are not offered for public purchase outside of Switzerland, especially not in the United States of America.